Good Morning, It's Thursday February 2nd, 2012,...
(more)
Good Morning, It's Thursday February 2nd, 2012, I'm Christina Collins with CRWENewswire Stocks In Action
StemCells Incorporated - symbol STEM - reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration
(less)
|
|
